For many of us, our urologists arrived in our lives at a time of crisis and have confined their care to managing our prostate cancer diagnosis, treatment, and follow-up. But in an engaging ...

Here's a growing list of the approved hormone therapies, immunotherapies and targeted therapies for treating cancer. Click on any of the drugs for more info on dosing, side effects and drug ...

Sometimes life can be a precarious balancing act. This balance can be disrupted in any number of ways – including the loss of a job or a divorce or a cancer diagnosis. Traumas like this can lead to ...

While new cancer diagnoses have decreased overall since the 1990s, increases in obesity-related cancers are likely slowing this progress, according to the CDC. About two thirds of U.S. adults and ...

About his book. “I wrote it for a specific reason. I had spent my whole career as an expert on care. I myself was a psychiatrist who worked with patients with chronic medical disorders, [such as] ...

About 33% of all brain tumors are gliomas, and they are categorized into various types, according to Johns Hopkins Medicine. Treatment for a glioma depends on its grade but many people, including ...

Researchers studied 165,887 men and women 50 to 66 years old who had received one colonoscopy with a negative result. The group was followed for up to 17.4 years past that test. During that time, this ...

The Biden Initiative had begun to make progress toward those goals before it closed its doors for good. It created the Oncology Clinical Trial Information Commons, a collaboration among nine ...

Joining a Clinical Trial for Treatment Triple-negative breast cancer, an aggressive type of invasive breast cancer, grows and spreads more quickly and has fewer treatment options than other types ...

Ginsburg has battled cancer multiple times. In 1999, she was successfully treated for colon cancer, and in 2009, she had surgery to treat early stage pancreatic cancer. A decade later, in December ...

If this is the first time you’ve heard about the financial reality of cancer, I hope you won’t turn away. I know it’s hard to wrap your head around and heartbreaking to witness—but if families have to ...

Overall, people who used GLP-1 agonists had a 7% lower risk of developing obesity-related cancers than those who used DPP-4 inhibitors. The effect was more pronounced for women, who had an 8% lower ...